Cart
sales@molnova.com
gp120-α4β7 binding inhibitor 11
CAS No. 869474-87-3
gp120-α4β7 binding inhibitor 11( —— )
Catalog No. M35947 CAS No. 869474-87-3
gp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 193 | In Stock |
|
| 5MG | 179 | In Stock |
|
| 10MG | 263 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 542 | In Stock |
|
| 100MG | 728 | In Stock |
|
| 200MG | 986 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namegp120-α4β7 binding inhibitor 11
-
NoteResearch use only, not for human use.
-
Brief Descriptiongp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM).
-
Descriptiongp120-α4β7 binding inhibitor 11 is an anti-HIV agent. gp120-α4β7 binding inhibitor 11 interferes the binding of HIV associated glycoprotein gp12G with the integrin α4β7 (IC50=1.64nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV Protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number869474-87-3
-
Formula Weight413.51
-
Molecular FormulaC26H27N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(NC1=C(C(NCC2=CC=C(C)C=C2)=O)C=CC=C1)=O)N3CC=4C(CC3)=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
D77
A potent inhibitor of HIV-1 integrase-LEDGF/p75 interaction; binds to IN and IN(T125A) with Kd of 5.81 and 15.2 uM.
-
HIV-1 inhibitor-6?
3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- is a potent HIV-1 pre-mRNA selective splicing inhibitor that blocks HIV replication.
-
BMS-488043
BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.
